NO885113D0 - Monoklonalt antistoff som gjenkjenner alfa-2-3-bindinger. - Google Patents

Monoklonalt antistoff som gjenkjenner alfa-2-3-bindinger.

Info

Publication number
NO885113D0
NO885113D0 NO885113A NO885113A NO885113D0 NO 885113 D0 NO885113 D0 NO 885113D0 NO 885113 A NO885113 A NO 885113A NO 885113 A NO885113 A NO 885113A NO 885113 D0 NO885113 D0 NO 885113D0
Authority
NO
Norway
Prior art keywords
monoclonal antibody
hybridoma
bindings
alfa
recognizes
Prior art date
Application number
NO885113A
Other languages
English (en)
Other versions
NO173556B (no
NO885113L (no
NO173556C (no
Inventor
Yoshitaka Nagai
Hideki Yamamoto
Kinji Takada
Masayoshi Ito
Yoshiyasu Shitori
Original Assignee
Kanto Ishi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanto Ishi Pharma Co Ltd filed Critical Kanto Ishi Pharma Co Ltd
Publication of NO885113D0 publication Critical patent/NO885113D0/no
Publication of NO885113L publication Critical patent/NO885113L/no
Publication of NO173556B publication Critical patent/NO173556B/no
Publication of NO173556C publication Critical patent/NO173556C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57469—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving tumor associated glycolinkage, i.e. TAG
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/806—Drug, bio-affecting and body treating compositions involving IgM
    • Y10S424/807—Monoclonal
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y10S530/864—Monoclonal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO885113A 1987-11-17 1988-11-16 Monoklonalt antistoff som gjenkjenner alpha-2-3-bindinger, og hybridomcellelinje som produserer antistoffet NO173556C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62290310A JP2754206B2 (ja) 1987-11-17 1987-11-17 α２→３結合を認識するモノクローナル抗体

Publications (4)

Publication Number Publication Date
NO885113D0 true NO885113D0 (no) 1988-11-16
NO885113L NO885113L (no) 1989-05-18
NO173556B NO173556B (no) 1993-09-20
NO173556C NO173556C (no) 1993-12-29

Family

ID=17754449

Family Applications (1)

Application Number Title Priority Date Filing Date
NO885113A NO173556C (no) 1987-11-17 1988-11-16 Monoklonalt antistoff som gjenkjenner alpha-2-3-bindinger, og hybridomcellelinje som produserer antistoffet

Country Status (14)

Country Link
US (1) US5141864A (no)
EP (1) EP0316882B1 (no)
JP (1) JP2754206B2 (no)
KR (1) KR960014441B1 (no)
CN (1) CN1042734A (no)
AT (1) ATE108482T1 (no)
AU (1) AU624583B2 (no)
CA (1) CA1337800C (no)
DE (1) DE3850634T2 (no)
FI (1) FI95043C (no)
HU (1) HU204573B (no)
IL (1) IL88400A (no)
NO (1) NO173556C (no)
NZ (1) NZ226974A (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4107154A1 (de) * 1990-10-11 1992-04-16 Boehringer Mannheim Gmbh Monoklonale antikoerper gegen melanom
DE4208795A1 (de) * 1992-03-19 1993-09-23 Behringwerke Ag Monoklonaler anti-gangliosid-antikoerper, seine herstellung und verwendung als tumortherapeutikum
CN1057128C (zh) * 1993-09-22 2000-10-04 南通医学院 感觉神经抗体及其制备方法
US5674681A (en) * 1994-12-06 1997-10-07 Rothenberg; Barry E. Methods to identify hemochromatosis
CU23007A1 (es) * 2001-04-06 2004-12-17 Ct De Inmunologia Molecular Ct De Inmunologia Mole Combinaciones inmunoterapéuticas para el tratamiencombinaciones inmunoterapéuticas para el tratamiento de tumores que sobre-expresan gangliósidos to de tumores que sobre-expresan gangliósidos
CN100347296C (zh) * 2003-03-28 2007-11-07 财团法人富山县新世纪产业机构 使用单个抗原特异性b淋巴细胞制备产生抗原特异性抗体的杂交瘤的方法以及单克隆抗体的制备方法
FI20070199A0 (fi) * 2007-03-08 2007-03-08 Glykos Finland Oy Uusia happamia N-glykaanirakenteita
EP2606897A1 (en) 2011-12-22 2013-06-26 Laboratorios Del. Dr. Esteve, S.A. Methods and compositions for the treatment of diseases caused by enveloped viruses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507391A (en) * 1982-04-02 1985-03-26 Sloan-Kettering Institute For Cancer Research Method for detecting the presence of GD3 ganglioside

Also Published As

Publication number Publication date
HUT48679A (en) 1989-06-28
NO173556B (no) 1993-09-20
IL88400A (en) 1993-06-10
FI885279A0 (fi) 1988-11-15
DE3850634T2 (de) 1994-10-27
EP0316882A2 (en) 1989-05-24
DE3850634D1 (de) 1994-08-18
HU204573B (en) 1992-01-28
KR960014441B1 (ko) 1996-10-15
NO885113L (no) 1989-05-18
AU2518688A (en) 1989-05-25
CA1337800C (en) 1995-12-26
EP0316882A3 (en) 1990-03-14
ATE108482T1 (de) 1994-07-15
JPH01132374A (ja) 1989-05-24
JP2754206B2 (ja) 1998-05-20
US5141864A (en) 1992-08-25
CN1042734A (zh) 1990-06-06
FI885279A (fi) 1989-05-18
NZ226974A (en) 1990-03-27
FI95043C (fi) 1995-12-11
FI95043B (fi) 1995-08-31
KR890008320A (ko) 1989-07-10
NO173556C (no) 1993-12-29
AU624583B2 (en) 1992-06-18
IL88400A0 (en) 1989-06-30
EP0316882B1 (en) 1994-07-13

Similar Documents

Publication Publication Date Title
PT86792A (pt) Monoclonal antibodies against melanoma-associated antigens hybrid cell lines producing these antibodies and use therefor
DK609985A (da) Adhesin-antigener, antistoffer mod disse og dna-fragmenter, som indkoder antigenerne
PH20552A (en) Therapeutic composition employing mouse monoclonal antibody of class igg
YU45068B (en) Process for obtaining a monoclonal antibody which is fixing a complement
NO885113L (no) Monoklonalt antistoff som gjenkjenner alfa-2-3-bindinger.
DK392387A (da) Monoklonalt antistrof til diagnostisk anvendelse og fremgangsmaade til fremstilling af et saadan antistof
EP0251195A3 (en) Method and reagent for the determination of alpha-amylase
NO174855C (no) Monoklonalt antistoff og cellelinje som produserer dette
ES2045027T3 (es) Igm purificadas.
DE3579868D1 (de) Stabilisierung von monoklonalen antikoerpern.
FI873233A0 (fi) Modifierade virala glykoproteiner.
AU3718784A (en) Antibodies and antibody containing compositions for inhibiting gingivitis
SE8704114D0 (sv) Monoclonal antibody, a process for its preparation and the use thereof
DE68914054D1 (de) Monoklonale Antikörper mit der Fähigkeit zur Erkennung von Gangliosiden GQ1b und GT1a.